Immunomodulatory activity of IR700-labelled affibody targeting HER2

There is an urgent need to develop therapeutic approaches that can increase the response rate to immuno-oncology agents. Photoimmunotherapy has recently been shown to generate anti-tumour immunological responses by releasing tumour-associated antigens from ablated tumour cell residues, thereby enhan...

Descripción completa

Detalles Bibliográficos
Autores principales: Mączyńska, Justyna, Da Pieve, Chiara, Burley, Thomas A., Raes, Florian, Shah, Anant, Saczko, Jolanta, Harrington, Kevin J., Kramer-Marek, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576828/
https://www.ncbi.nlm.nih.gov/pubmed/33082328
http://dx.doi.org/10.1038/s41419-020-03077-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576828/
https://www.ncbi.nlm.nih.gov/pubmed/33082328
http://dx.doi.org/10.1038/s41419-020-03077-6

Ejemplares similares